Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK

被引:41
作者
Allain, JP
Palmer, CR
Pearson, G
机构
[1] Univ Cambridge, E Anglian Blood Ctr, Div Transfus Med, Cambridge CB2 2PT, England
[2] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 2SR, England
关键词
D O I
10.1016/S0163-4453(98)80012-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Aims: To determine the prevalence of IgG and IgM to Toxoplasma gondii (TG) and predict the incidence of infection during pregnancy and in foetuses. Methods: Thirteen thousand pregnant women from eastern England were tested at the time of booking for antenatal screening. Screening was carried out for the presence of IgG and IgM anti-TG, followed by confirmation with commercially available assays, Results: Latent infection to TG was found in 7.7% of women and increased with age from 6.8 to 17.8%, Recent infection accounted for an additional 0.4% equally distributed across age groups, No difference was found between urban and rural place of residence. A 1-2% incidence of TG infection every 5 years of age was found, IgM-only cases were mostly false positives and were unsuitable for statistical analysis, On the basis of both IgM and IgG imputed data, TG infection was found significantly higher during the first trimester of pregnancy, Three to sixteen TG-infected foetuses per 10 000 pregnancies were predicted, Conclusions: The east of England has a low prevalence of TG infection and therefore a high, at-risk population of pregnant women. Repeated screening during pregnancy would be expensive, but would detect and possibly prevent infection in approximately 10 neonates per 10 000 women.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 24 条
  • [1] METHODS FOR ESTIMATING THE INCIDENCE OF PRIMARY INFECTION IN PREGNANCY - A REAPPRAISAL OF TOXOPLASMOSIS AND CYTOMEGALOVIRUS DATA
    ADES, AE
    [J]. EPIDEMIOLOGY AND INFECTION, 1992, 108 (02) : 367 - 375
  • [2] MODELING AGE-SPECIFIC AND TIME-SPECIFIC INCIDENCE FROM SEROPREVALENCE - TOXOPLASMOSIS
    ADES, AE
    NOKES, DJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) : 1022 - 1034
  • [3] Altman DG, 1990, PRACTICAL STAT MED R
  • [4] COMPARISON OF RELATIVE USES OF COMMERCIAL ASSAYS FOR TOXOPLASMA-GONDII IGM ANTIBODIES
    ASHBURN, D
    EVANS, R
    SKINNER, LJ
    CHATTERTON, JMW
    JOSS, AWL
    HOYEN, DO
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (06) : 483 - 486
  • [5] BERREBI A, 1994, LANCET, V344, P35
  • [6] PRENATAL MANAGEMENT OF 746 PREGNANCIES AT RISK FOR CONGENITAL TOXOPLASMOSIS
    DAFFOS, F
    FORESTIER, F
    CAPELLAPAVLOVSKY, M
    THULLIEZ, P
    AUFRANT, C
    VALENTI, D
    COX, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (05) : 271 - 275
  • [7] DECOSTER A, 1988, LANCET, V2, P1104
  • [8] DESMONTS G, 1974, B NEW YORK ACAD MED, V50, P146
  • [9] ASSESSMENT OF IMMUNOGLOBULIN-M IMMUNOSORBENT AGGLUTINATION ASSAY (ISAGA) FOR DETECTING TOXOPLASMA SPECIFIC IGM
    DUFFY, KMT
    WHARTON, PJ
    JOHNSON, JD
    NEW, L
    HOLLIMAN, RE
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (12) : 1291 - 1295
  • [10] TOXOPLASMA-GONDII ANTIBODIES IN PREGNANT-WOMEN IN STOCKHOLM IN 1969, 1979, AND 1987
    FORSGREN, M
    GILLE, E
    LJUNGSTROM, I
    NOKES, DJ
    [J]. LANCET, 1991, 337 (8754) : 1413 - 1414